Pastores GM - Search Results

1

Enzyme replacement therapy for Anderson-Fabry disease.

El Dib RP, Nascimento P, Pastores GM. El Dib RP, et al. Among authors: pastores gm. Cochrane Database Syst Rev. 2013 Feb 28;(2):CD006663. doi: 10.1002/14651858.CD006663.pub3. Cochrane Database Syst Rev. 2013. PMID: 23450571 Updated. Review.

2

Enzyme replacement therapy for Anderson-Fabry disease.

El Dib RP, Pastores GM. El Dib RP, et al. Among authors: pastores gm. Cochrane Database Syst Rev. 2010 May 12;(5):CD006663. doi: 10.1002/14651858.CD006663.pub2. Cochrane Database Syst Rev. 2010. PMID: 20464743 Updated. Review.

3

Laronidase for treating mucopolysaccharidosis type I.

El Dib RP, Pastores GM. El Dib RP, et al. Among authors: pastores gm. Genet Mol Res. 2007 Sep 30;6(3):667-74. Genet Mol Res. 2007. PMID: 18050087 Free article. Review.

4

A systematic review of new advances in the management of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): focus on galsulfase.

El Dib RP, Pastores GM. El Dib RP, et al. Among authors: pastores gm. Biologics. 2009;3:459-68. doi: 10.2147/btt.2009.3580. Epub 2009 Oct 12. Biologics. 2009. PMID: 19851471 Free PMC article.

5

Effects of enzyme replacement therapy in Fabry disease--a comprehensive review of the medical literature.

Lidove O, West ML, Pintos-Morell G, Reisin R, Nicholls K, Figuera LE, Parini R, Carvalho LR, Kampmann C, Pastores GM, Mehta A. Lidove O, et al. Among authors: pastores gm. Genet Med. 2010 Nov;12(11):668-79. doi: 10.1097/GIM.0b013e3181f13b75. Genet Med. 2010. PMID: 20962662 Free article. Review.

6

Long-term effectiveness of enzyme replacement therapy in Fabry disease: results from the NCS-LSD cohort study.

Anderson LJ, Wyatt KM, Henley W, Nikolaou V, Waldek S, Hughes DA, Pastores GM, Logan S. Anderson LJ, et al. Among authors: pastores gm. J Inherit Metab Dis. 2014 Nov;37(6):969-78. doi: 10.1007/s10545-014-9717-4. Epub 2014 May 15. J Inherit Metab Dis. 2014. PMID: 24831586

7

Agalsidase alfa in pediatric patients with Fabry disease: a 6.5-year open-label follow-up study.

Schiffmann R, Pastores GM, Lien YH, Castaneda V, Chang P, Martin R, Wijatyk A. Schiffmann R, et al. Among authors: pastores gm. Orphanet J Rare Dis. 2014 Nov 26;9:169. doi: 10.1186/s13023-014-0169-6. Orphanet J Rare Dis. 2014. PMID: 25425121 Free PMC article. Clinical Trial.

8

Advances in the management of Anderson-Fabry disease: enzyme replacement therapy.

Pastores GM, Thadhani R. Pastores GM, et al. Expert Opin Biol Ther. 2002 Mar;2(3):325-33. doi: 10.1517/14712598.2.3.325. Expert Opin Biol Ther. 2002. PMID: 11890871 Review.

9

Enzyme replacement therapy in Fabry disease: comparison of agalsidase alfa and agalsidase beta.

Mehta A, Beck M, Kampmann C, Frustaci A, Germain DP, Pastores GM, Sunder-Plassmann G. Mehta A, et al. Among authors: pastores gm. Mol Genet Metab. 2008 Sep-Oct;95(1-2):114-5. doi: 10.1016/j.ymgme.2008.07.002. Epub 2008 Aug 12. Mol Genet Metab. 2008. PMID: 18701330 No abstract available.

10

To see a world in a grain of sand: elucidating the pathophysiology of Anderson-Fabry disease through investigations of a cellular model.

Pastores GM, Hughes DA. Pastores GM, et al. Kidney Int. 2009 Feb;75(4):351-3. doi: 10.1038/ki.2008.606. Kidney Int. 2009. PMID: 19180148 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

202 results

Search Page